@ghtcoalition.org
Our mission is to advance innovation to save lives. GHTC is the leading advocacy organization working to accelerate R&D for #GlobalHealth technologies. #Innovate4Health
@ghtcoalition.org#AMR is steadily reducing our arsenal of tools to address deadly infections. We urgently need new #antimicrobials and antimicrobial alternatives, as well as new #diagnostics and #vaccines. Learn more about breakthrough technologies in development 🔬💉➡️bit.ly/AMR-FS
@mmv.orgReposted by @ghtcoalition.orgWhere medicines are made impacts who can access them.
Africa is heavily reliant on imports for the medicines needed to fight #malaria.
MMV works with African manufacturers and Africa CDC to strengthen local production and bring medicines closer to patients. bit.ly/4zc2X4m
@ghtcoalition.org
@ghtcoalition.orgUS #GlobalHealth R&D investments save lives, strengthen health security, and support the US economy. When research is cut short, progress, people, and preparedness suffer. Explore these impacts in our Innovation Interrupted tool: bit.ly/3RKTkcK
@cepi.netReposted by @ghtcoalition.orgA new early-stage trial assessing @ox.ac.uk's Bundibugyo ebolavirus vaccine candidate has launched in Uganda.
The CEPI-funded study is being conducted by MRC/UVRI & LSHTM Uganda Research Unit with @ovg.ox.ac.uk and Pandemic Sciences Institute and the Serum Institute of India manufacturing doses.
@dndi.orgReposted by @ghtcoalition.orgPleased to launch our first drug discovery partnership in Africa with KNUST. We’ll screen 100 compounds against schistosomiasis parasites, to develop the next gen of treatments while strengthening African-led drug discovery capacity. Supported by the BMFTR. www.dndi.org/press-releas...
@ghtcoalition.org🚨Kyle House Group & the University of Utah are cohosting a congressional event on Friday in Salt Lake City bringing together the university community and state leaders to discuss Utah’s contributions to advancing global health and development.
Register here! docs.google.com/forms/d/e/1F...
@ghtcoalition.orgWhat's new in #GlobalHealth R&D?
🧪Pooled #TB testing
🦟Promising #malaria drug
💊Antifungal development funding
@ghtcoalition.orgOur six-part US agency fact sheet series examines the contributions of key US agencies to #GlobalHealth R&D, looking at each agency’s unique role, how it invests across health areas, and success stories of its impact. Check it out ⬇️
@mmv.orgReposted by @ghtcoalition.orgFollowing encouraging Phase 2a results, MMV will lead the next phase of cabamiquine's development.
Long-acting cabamiquine, with potential to become a single-dose treatment or prevention option, could help address drug resistance & block transmission: bit.ly/4ypoy9x
@ghtcoalition.orgAs AI continues to rapidly transform many aspects of technology and science, including health research, a new report from @who.int speaks to how stakeholders can help ensure AI-enabled health research is conducted responsibly and benefits everyone.
@ghtcoalition.orgWhat’s the difference between a patent pool and a pooled fund? Check out our #GlobalHealth R&D dictionary to learn more. 🌍🕮
@cepi.netReposted by @ghtcoalition.orgAs global health leaders ready themselves for this year’s World Health Summit Health Summit in Berlin, CEPI invites you to join its official panel discussion, From Crisis Response to Resilience: Innovating for Health Security Beyond Borders.
@ghtcoalition.orgThe first participants have been vaccinated in a trial in the DRC, where the country’s ongoing outbreak of the #Bundibugyo strain of #Ebola has now become the largest Ebola outbreak in the country’s history and the second largest in history.
@gardp.bsky.socialReposted by @ghtcoalition.org🤝 GARDP and @dndi.org are pleased to announce support from the Foundation for the Adaptation of International Geneva to strengthen collaboration, share capabilities and resources, and help both focus more on developing and ensuring access to treatments for NTDs and drug-resistant infections.
@cepi.netReposted by @ghtcoalition.orgNew funding: The @bioprevail.bsky.social x CEPI Biosecurity Innovation Challenge is seeking practical biosafety and biosecurity innovations to strengthen vaccine R&D and manufacturing during epidemic and pandemic responses, supporting CEPI’s 100 Days Mission: bioprevail.org/challenge/bi...
@ghtcoalition.orgRecent results from a trial testing a new regimen for people with chronic T. cruzi infection could offer a safer, more practical treatment option for the infection, which affects more than seven million people globally.
@ghtcoalition.orgWhat's new in #GlobalHealth R&D?
💊Shorter #Chagas treatment regimen
💉 #Ebola vaccine trial
🖥️AI in health research report
@ghtcoalition.orgEnsuring everyone globally who wishes to use contraception has access to safe, effective, and acceptable options will require a variety of new and improved contraceptive choices. Check out some tools in pipeline! #WorldContraceptionDay
@ghtcoalition.org@cepi.net recently announced that it is awarding $3.9 million to support research projects aimed at improving understanding of the #Bundibugyo ebolavirus behind the ongoing outbreak in the Democratic Republic of the Congo.
